TRCT
TENX icon

Tower Research Capital (TRC)’s Tenax Therapeutics TENX Stock Holding History

Tower Research Capital (TRC)’s Portfolio TENX Stock Details TENX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$33.6K Buy
2,308
+1,208
+110% +$15.4K ﹤0.01% 3078
2026
Q1 		$17.6K Buy
1,100
+901
+453% +$12.2K ﹤0.01% 3574
2025
Q4 		$2.43K Sell
199
-302
-60% -$2.63K ﹤0.01% 4529
2025
Q3 		$3.81K Sell
501
-748
-60% -$4.57K ﹤0.01% 4447
2025
Q2 		$7.19K Buy
1,249
+1,057
+551% +$6.11K ﹤0.01% 4069
2025
Q1 		$1.26K Buy
+192
New +$1.23K ﹤0.01% 4747
2024
Q4 		– Sell
-1,693
Closed -$5.86K – 6003
2024
Q3 		$5.86K Buy
1,693
+732
+76% +$2.65K ﹤0.01% 4209
2024
Q2 		$2.9K Buy
961
+424
+79% +$1.5K ﹤0.01% 4950
2024
Q1 		$2.28K Buy
537
+480
+842% +$3.68K ﹤0.01% 5081
2023
Q4 		$1.25K Sell
57
-1
-2% -$24 ﹤0.01% 5410
2023
Q3 		$1.39K Hold
58
– – ﹤0.01% 5345
2023
Q2 		$1.4K Sell
58
-8
-12% -$213 ﹤0.01% 5385
2023
Q1 		$2K Buy
66
+60
+1,000% +$6.26K ﹤0.01% 5403
2022
Q4 		$1K Hold
6
– – ﹤0.01% 5671
2022
Q3 		$2K Hold
6
– – ﹤0.01% 5617
2022
Q2 		$3K Buy
6
+3
+100% +$3K ﹤0.01% 5413
2022
Q1 		$4K Hold
3
– – ﹤0.01% 5253
2021
Q4 		$5K Buy
+3
New +$6.76K ﹤0.01% 5193
2021
Q3 		– Sell
-1
Closed -$2.62K – 6166
2021
Q2 		$3K Buy
+1
New +$3.17K ﹤0.01% 4960
2021
Q1 		– Sell
-11
Closed -$39.3K – 5218
2020
Q4 		$33K Buy
11
+8
+267% +$14.7K ﹤0.01% 3498
2020
Q3 		$8K Buy
+3
New +$6.4K ﹤0.01% 4195
2017
Q3 		– Hold
0
– -$10K – 4137
2017
Q2 		– Hold
0
– – – 1619
2016
Q3 		– Hold
0
– -$3K – 4427
2016
Q2 		– Hold
0
– – – 3743
2016
Q1 		– Hold
0
– – – 3166
2015
Q4 		– Hold
0
– – – 4161
2015
Q3 		– Hold
0
– – – 1586
2015
Q2 		– Hold
0
– – – 3796
2015
Q1 		– Hold
0
– – – 2304
2014
Q4 		– Hold
0
– – – 2925
2014
Q3 		– Hold
0
– – – 2905
2014
Q1 		– Sell
-1
Closed -$79K – 4914
2013
Q4 		$79K Buy
+1
New +$135K 0.01% 1000
2013
Q3 		– Hold
0
– -$1K – 4838
2013
Q2 		– Hold
0
– – – 3741

Other funds holding TENX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $22.2B AUM 58.34% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

Tower Research Capital (TRC)'s TENX Position: Q2 2026 in Review

Tower Research Capital (TRC) increased its Tenax Therapeutics (TENX) stake by 110% in Q2 2026, buying an estimated $15.4K and bringing the position to 2,308 shares worth $33.6K. The position accounts for ﹤0.01% of the portfolio, ranked #3078.

Tower Research Capital (TRC) first reported a position in TENX in Q4 2013 and has held it in 22 quarters since. The position peaked at $79K in Q4 2013. 111 funds tracked by Wall St. Rank hold TENX as of Q2 2026.

  • Tower Research Capital (TRC) held 2,308 shares of Tenax Therapeutics worth $33.6K as of Q2 2026.
  • Tower Research Capital (TRC) bought 1,208 Tenax Therapeutics shares in Q2 2026, an estimated $15.4K.
  • Tenax Therapeutics made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q2 2026, its #3078 holding.
  • Tower Research Capital (TRC) first reported a position in Tenax Therapeutics in Q4 2013 and has held it in 22 quarters since.
  • Tower Research Capital (TRC)'s Tenax Therapeutics position peaked at $79K in Q4 2013.
  • 111 funds tracked by Wall St. Rank held Tenax Therapeutics as of Q2 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2026, filed 11 Aug 2026.